Literature DB >> 2221859

Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells.

D Raoult1, M Drancourt, G Vestris.   

Abstract

There is no consistently reliable treatment for endocarditis resulting from chronic Coxiella burnetii infection, the causative agent of Q fever. Although certain antibiotics are recommended on the basis of their in vitro bactericidal activities, results of therapy with these antibiotics are often disappointing. To evaluate whether the currently recommended antibiotic susceptibility tests for C. burnetii give misleading results because of continued division of uninfected cells, thereby resulting in the dilution of infected cells and, hence, a false picture of antibiotic efficacy, we blocked cell division during antibiotic susceptibility testing with cycloheximide. Using this new method, we found that the currently recommended antibiotics for the treatment of Q fever, doxycycline, pefloxacin, and rifampin, did not reduce the ratio of infected to noninfected cells (either L929 or P388D1) by 9 days postinfection. To test the hypothesis that this lack of antibacterial activity is due to antibiotic inactivation by the low pH of the phagolysosomes in which C. burnetii is found, we used alkalinizing lysosomotropic agents (chloroquine or amantadine) concurrently with doxycycline. This resulted in the sterilization of C. burnetii infection in P388D1 cells. This finding seems to confirm our suspicion that the acidic conditions of the phagolysosomes in which C. burnetii is located inhibit antibiotic activity. This inhibition can be reversed in vitro when lysosomotropic alkalinizing agents are used.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221859      PMCID: PMC171863          DOI: 10.1128/AAC.34.8.1512

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  The comparative effectiveness of aureomycin, terramycin, chloramphenicol erythromycin, and thiocymetin in suppressing experimental rickettsial infections in chick embryos.

Authors:  R A ORMSBEE; H PARKER; E G PICKENS
Journal:  J Infect Dis       Date:  1955 Mar-Apr       Impact factor: 5.226

2.  In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.

Authors:  M Walsh; E W Kappus; T C Quinn
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes.

Authors:  M R Yeaman; M J Roman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Q fever endocarditis in the south of France.

Authors:  D Raoult; J Etienne; P Massip; S Iaocono; M A Prince; P Beaurain; S Benichou; J C Auvergnat; P Mathieu; P Bachet
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

Review 5.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

Review 6.  Q fever and Coxiella burnetii: a model for host-parasite interactions.

Authors:  O G Baca; D Paretsky
Journal:  Microbiol Rev       Date:  1983-06

7.  Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines.

Authors:  O G Baca; E T Akporiaye; A S Aragon; I L Martinez; M V Robles; N L Warner
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Susceptibility of Coxiella burnetii to pefloxacin and ofloxacin in ovo and in persistently infected L929 cells.

Authors:  D Raoult; M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

9.  Apparent recurrence of Q fever endocarditis following homograft replacement of aortic valve.

Authors:  H D Tunstall Pedoe
Journal:  Br Heart J       Date:  1970-07

10.  In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones.

Authors:  M R Yeaman; L A Mitscher; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

View more
  48 in total

1.  Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection.

Authors:  M Maurin; A M Benoliel; P Bongrand; D Raoult
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis.

Authors:  P Y Levy; M Drancourt; J Etienne; J C Auvergnat; J Beytout; J M Sainty; F Goldstein; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.

Authors:  D Raoult; H Torres; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Intracellular microorganisms: a particular problem for chemotherapy. Introduction.

Authors:  H Hof
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 5.  Optimum treatment of intracellular infection.

Authors:  M Maurin; D Raoult
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

6.  Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay.

Authors:  Robert E Brennan; James E Samuel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

7.  Q Fever Presenting As Recurrent, Culture-negative Endocarditis with Aortic Prosthetic Valve Failure: A Case Report and Review of the Literature.

Authors:  Abeer N Alshukairi; Muhammad G Morshed; Neil E Reiner
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-11       Impact factor: 2.471

8.  In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.

Authors:  N Jabarit-Aldighieri; H Torres; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 10.  Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.